UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis

JNCI : Journal of the National Cancer Institute, 2015-12, Vol.107 (12), p.djv275-djv275

2015

Volltextzugriff (PDF)

Ancillary Treatment Referrals and Visits After Breast Cancer Surgery in a Sociodemographically Diverse Population

Annals of surgical oncology, 2023-09, Vol.30 (9), p.5637-5648

2023

Volltextzugriff (PDF)

Patient preferences regarding incidental genomic findings discovered during tumor profiling

Cancer, 2016-05, Vol.122 (10), p.1588-1597

2016

Volltextzugriff (PDF)

Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States

Cancer, 2015-08, Vol.121 (15), p.2544-2552

2015

Volltextzugriff (PDF)

ASO Author Reflections: Ancillary Treatment After Breast Cancer Surgery: Who are We Missing?

Annals of surgical oncology, 2023-09, Vol.30 (9), p.5649-5650

2023

Volltextzugriff (PDF)

ASO Visual Abstract: Ancillary Treatment Referrals and Visits After Breast Cancer Surgery in a Sociodemographically Diverse Population

Annals of surgical oncology, 2023-09, Vol.30 (9), p.5651-5652

2023

Volltextzugriff (PDF)

Delivery of Cancer Survivorship Education to Community Healthcare Professionals

Journal of cancer education, 2023-04, Vol.38 (2), p.625-631

2023

Volltextzugriff (PDF)

Musculoskeletal Effects of Antineoplastic Agents

Journal of the American Academy of Orthopaedic Surgeons, 2019-11, Vol.27 (22), p.834

2019

Volltextzugriff (PDF)

Impact of the Breast Cancer Index for Extended Endocrine Decision-Making: First Results of the Prospective BCI Registry Study

Journal of the National Comprehensive Cancer Network, 2024-03, Vol.22 (2), p.99

2024

Volltextzugriff (PDF)

Palliative care across the continuum of cancer care

Journal of the National Comprehensive Cancer Network, 2009-04, Vol.7 (4), p.481

2009

Volltextzugriff (PDF)

Defining the patient experience in medical oncology

Journal of clinical oncology, 2018-10, Vol.36 (30_suppl), p.167-167

2018

Volltextzugriff (PDF)

Ancillary treatment referrals and visits after breast cancer surgery in a sociodemographically diverse population

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1533-1533

2022

Volltextzugriff (PDF)

A multifaceted approach to wellness in a hematology/oncology fellowship program

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11006-11006

2023

Volltextzugriff (PDF)

Trends in breast cancer death by stage at diagnoses in 2000-2018

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e18855-e18855

2023

Volltextzugriff (PDF)

The brown university cancer prevention and survivorship curriculum: A case study on program development in an internal medicine residency

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.11031-11031

2023

Volltextzugriff (PDF)

Adherence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor (HR)-positive breast cancers

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.527-527

2020

Volltextzugriff (PDF)

Delivery of cancer survivorship education to community health care professionals

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.11032-11032

2020

Volltextzugriff (PDF)

With a little help from my friends: A multi-disciplinary approach to cancer survivorship

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e24082-e24082

2020

Volltextzugriff (PDF)

The Breast Cancer Index Registry Study: Initial analysis of the first 1,000 patients

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e12513-e12513

2022

Volltextzugriff (PDF)

Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivors

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e12501-e12501

2021

Volltextzugriff (PDF)

How did the COVID crisis affect use of neoadjuvant therapy for patients with breast cancer?

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18708-e18708

2021

Volltextzugriff (PDF)

Oral paclitaxel and dostarlimab with or without trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant ISPY 2 TRIAL

Journal of clinical oncology, 2023-06, Vol.41 (17_suppl), p.LBA612-LBA612

2023

Volltextzugriff (PDF)

Randomized trial of diet and exercise on chemotherapy completion in women with breast cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.12007-12007

2022

Volltextzugriff (PDF)

A randomized trial of a healthy lifestyle intervention versus usual care on chemotherapy and endocrine therapy adherence rate in women with breast cancer: The Lifestyle Exercise and Nutrition Early After Diagnosis (LEANER) Study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS11633-TPS11633

2019

Volltextzugriff (PDF)

Triplet therapy (continuous ribociclib, everolimus, exemestane) in HR+/HER2− advanced breast cancer postprogression on a CDK4/6 inhibitor (TRINITI-1): Efficacy, safety, and biomarker results

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.1016-1016

2019

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis

Ancillary Treatment Referrals and Visits After Breast Cancer Surgery in a Sociodemographically Diverse Population

Patient preferences regarding incidental genomic findings discovered during tumor profiling

Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States

ASO Author Reflections: Ancillary Treatment After Breast Cancer Surgery: Who are We Missing?

ASO Visual Abstract: Ancillary Treatment Referrals and Visits After Breast Cancer Surgery in a Sociodemographically Diverse Population

Delivery of Cancer Survivorship Education to Community Healthcare Professionals

Musculoskeletal Effects of Antineoplastic Agents

Impact of the Breast Cancer Index for Extended Endocrine Decision-Making: First Results of the Prospective BCI Registry Study

Palliative care across the continuum of cancer care

Defining the patient experience in medical oncology

Ancillary treatment referrals and visits after breast cancer surgery in a sociodemographically diverse population

A multifaceted approach to wellness in a hematology/oncology fellowship program

Trends in breast cancer death by stage at diagnoses in 2000-2018

The brown university cancer prevention and survivorship curriculum: A case study on program development in an internal medicine residency

Adherence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor (HR)-positive breast cancers

Delivery of cancer survivorship education to community health care professionals

With a little help from my friends: A multi-disciplinary approach to cancer survivorship

The Breast Cancer Index Registry Study: Initial analysis of the first 1,000 patients

Impact of a randomized weight loss trial on breast tissue markers in breast cancer survivors

How did the COVID crisis affect use of neoadjuvant therapy for patients with breast cancer?

Oral paclitaxel and dostarlimab with or without trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant ISPY 2 TRIAL

Randomized trial of diet and exercise on chemotherapy completion in women with breast cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) study

A randomized trial of a healthy lifestyle intervention versus usual care on chemotherapy and endocrine therapy adherence rate in women with breast cancer: The Lifestyle Exercise and Nutrition Early After Diagnosis (LEANER) Study

Triplet therapy (continuous ribociclib, everolimus, exemestane) in HR+/HER2− advanced breast cancer postprogression on a CDK4/6 inhibitor (TRINITI-1): Efficacy, safety, and biomarker results

Suchergebnisse filtern